Furthermore, in a randomized, double-blind, and placebo-controlled clinical trial, it was shown that vitamin D supplementation significantly improved the levels of Aβ-42, APP, and BACE1 in elderly patients with AD (224). This evidence concerns the gene APP and Alzheimer disease.